Since the pathophysiology of neointimal hyperplasia in SP shunts of infants with complex congenital heart disease remains largely unknown, we aimed to identify the role of EGFR and MMP-9 in the formation of neointima in SP shunts. Here, EGFR is linked to congenital heart disease.